Seminars in Radiation Oncology

Papers
(The median citation count of Seminars in Radiation Oncology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Biology of Radiation-Induced Lung Injury39
Epidemiology of HPV Related Malignancies35
Biology of HPV Mediated Carcinogenesis and Tumor Progression31
The Radiobiology of Radiopharmaceuticals29
The Role of Theranostics in Prostate Cancer22
Quality Assurance for AI-Based Applications in Radiation Therapy21
Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology19
Dosimetry for Optimized, Personalized Radiopharmaceutical Therapy18
Regulatory Aspects of the Use of Artificial Intelligence Medical Software18
Automated Tumor Segmentation in Radiotherapy17
Radiopharmaceutical Chemistry and Drug Development—What's Changed?16
Targeting the ATM Kinase to Enhance the Efficacy of Radiotherapy and Outcomes for Cancer Patients16
Biology of the Radio- and Chemo-Responsiveness in HPV Malignancies15
Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and Limitations15
Uncertainty Assessment for Deep Learning Radiotherapy Applications15
Artificial Intelligence for Radiation Oncology Applications Using Public Datasets15
Prevention and Screening of HPV Malignancies15
The Evolution of Geriatric Oncology and Geriatric Assessment over the Past Decade14
Radiopharmaceuticals for Neuroendocrine Tumors14
Artificial Intelligence for Image Registration in Radiation Oncology13
Chromosome Missegregation as a Modulator of Radiation Sensitivity13
Exclusion of Older Adults from Cancer Clinical Trials: Review of the Literature and Future Recommendations12
Targeting Non-homologous and Alternative End Joining Repair to Enhance Cancer Radiosensitivity12
Re-Irradiation of Recurrent Non-Small Cell Lung Cancer12
Theranostics: The Role of Quantitative Nuclear Medicine Imaging11
Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC11
Imaging and its Impact on Defining the Oligometastatic State11
Advances in Automated Treatment Planning10
Artificial Intelligence for Outcome Modeling in Radiotherapy10
Future Directions in the Use of SAbR for the Treatment of Oligometastatic Cancers9
Novel Agents and Future Perspectives on Theranostics9
The Biological Process of Aging and the Impact of Ionizing Radiation9
Radiotherapy-Poly(ADP-ribose) Polymerase Inhibitor Combinations: Progress to Date9
DCIS: Risk Assessment in the Molecular Era8
Local Therapies in Oligometastatic and Oligoprogressive Prostate Cancer8
Integrating Artificial Intelligence and Machine Learning Into Cancer Clinical Trials8
Potential of Deep Learning in Quantitative Magnetic Resonance Imaging for Personalized Radiotherapy7
Radiopharmaceuticals for Bone Metastases7
Pushing the Envelope: The Role of Radiation Therapy in Non-muscle-Invasive Bladder Cancer7
Challenges, Complexities, and Considerations in the Design and Interpretation of Late-Phase Oncology Trials7
The Spectrum of Metastasis: An Opportunity for Cure?7
Emerging Roles of Circulating Tumor DNA for Increased Precision and Personalization in Radiation Oncology7
Mechanisms of Immune Modulation by Radiation7
Tailoring the Omission of Radiotherapy for Early-Stage Breast Cancer Based on Tumor Biology6
Radiation and Modulation of the Tumor Immune Microenvironment in Non–Small Cell Lung Cancer6
Physics of Particle Beam and Hypofractionated Beam Delivery in NSCLC6
Immunotherapy for HPV Malignancies6
Seeing is Believing: State of the Art Imaging of Bladder Cancer6
Treatment De-intensification for HPV-associated Oropharyngeal Cancer: A Definitive Surgery Paradigm6
Bladder Cancer Radiation Oncology of the Future: Prognostic Modelling, Radiomics, and Treatment Planning With Artificial Intelligence6
Radiation Therapy in the Management of Adrenal Metastases6
The Promise and Future of Radiomics for Personalized Radiotherapy Dosing and Adaptation6
Artificial Intelligence and Deep Learning for Brachytherapy6
Bladder Preservation for Muscle-Invasive Bladder Cancer With Variant Histology6
Immunotherapy Combined with Radiation Therapy in Breast Cancer: A Rapidly Evolving Landscape6
Treatment Intensification in Locally Advanced/Unresectable NSCLC Through Combined Modality Treatment and Precision Dose Escalation5
Standardization of Artificial Intelligence Development in Radiotherapy5
Regional Nodal Management in the Setting of Up-Front Surgery5
Systemic Therapy for Mutation-Driven NSCLC5
Ethical Aspects of Artificial Intelligence in Radiation Oncology5
Oligometastatic Breast Cancer5
Precision Radiation for Brain Metastases With a Focus on Hypofractionated Stereotactic Radiosurgery5
The Rapid Evolution of Theranostics in Radiation Oncology5
Hypofractionation in Early Stage Non-Small Cell Lung Cancer5
Radiation Therapy at the End of-Life: Quality of Life and Financial Toxicity Considerations4
Hypoxia-Targeted Dose Painting in Radiotherapy4
Regional Nodal Management After Preoperative Systemic Therapy4
Translation of Precision Medicine Research Into Biomarker-Informed Care in Radiation Oncology4
Recognizing Frailty in Radiation Oncology Clinical Practice: Current Evidence and Future Directions4
Radiotherapy for Lung Metastases: Conventional to Stereotactic Body Radiation Therapy4
The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance4
Emerging Technologies in Mitigating the Risks of Cardiac Toxicity From Breast Radiotherapy4
The Role of Stereotactic Body Radiation Therapy in the Management of Liver Metastases4
Oncometabolites as Regulators of DNA Damage Response and Repair4
The Legacy of RTOG/NRG Protocols in Shaping Current Bladder Preservation Therapy in North America4
Radiation Therapy for Painful Bone Metastases: Fractionation, Recalcification, and Symptom Control4
Radiopharmaceutical Delivery for Theranostics: Pharmacokinetics and Pharmacodynamics4
Brain Metastases: Is There Still a Role for Whole-Brain Radiation Therapy?4
Multimodality Treatment with Radiotherapy and Immunotherapy in Older Adults: Rationale, Evolving Data, and Current Recommendations3
Emerging Paradigm of Consolidative Thoracic Radiotherapy in Oligometastatic NSCLC3
Myths About Bladder Preservation in Muscle-Invasive Bladder Cancer3
Mechanisms, Challenges, and Opportunities in Combined Radiation and Hormonal Therapies3
Chemoradiation for Anal Cancer: Clinical Outcomes and Strategies to Optimize the Therapeutic Ratio According to HPV Status3
Radiation Treatment Deintensification for HPV-Associated Oropharyngeal Cancer3
Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic Disease3
Rectal Cancer MRI Guided Radiotherapy: A Practical Review for the Physician3
Particle Beam Therapy for Cardiac-Sparing Radiotherapy in Non-Small Cell Lung Cancer2
MRI-Guided Radiotherapy for Prostate Cancer: Seeing is Believing2
Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas2
Target Volume Delineation and Patterns of Recurrence in the Modern Era2
Hypofractionation in Older Adults With Glioblastoma2
The Emerging Evidence Supporting Integration of Deep Regional Hyperthermia With Chemoradiation in Bladder Cancer2
Are We Ready for Life in the Fast Lane? A Critical Review of Preoperative Hypofractionated Radiotherapy for Localized Soft Tissue Sarcoma2
Technical Giants But Biologic Infants: Defining a More Sophisticated Role for Local Therapy in Metastatic Disease2
Real-World Data: Applications and Relevance to Cancer Clinical Trials2
MRI-Guided Adaptive Radiation Therapy2
Normal Tissue Toxicity Prediction: Clinical Translation on the Horizon2
Why De-Intensification is not Possible in HPV-Associated Cervical Cancer2
Integrating the Patient's Voice in Toxicity Reporting and Treatment Decisions for Breast Radiotherapy2
MRI-Guided Radiation Therapy—An Emerging and Disruptive Process of Care: Healthcare Economic and Policy Considerations2
Improving the Education of Radiation Oncology Professionals in Geriatric Oncology: Where Are We and Where Should We Be?2
Navigating the Critical Translational Questions for Implementing FLASH in the Clinic2
Intrafraction Motion Management With MR-Guided Radiation Therapy2
The Importance of Quality Assurance in Radiation Oncology Clinical Trials2
Exploring the Advantages and Challenges of MR-Guided Radiotherapy in Non–Small-Cell Lung Cancer: Who are the Optimal Candidates?2
Theranostics and Patient-Specific Dosimetry2
The Role of Ablative Radiotherapy in Older Adults With Limited Metastatic Disease2
The Quality Assurance of a 1.5 T MR-Linac2
0.032876014709473